Recently, the matrix metalloproteinase-1 (MMP1)-rich niche of breast cancer brain metastases (BCBMs) was exploited in the design of NPs that can escape abluminal LRP-1-mediated clearance. The gene discussed is MMP1; the disease is breast carcinoma.